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Mas-related G coupled receptors (Mrgprs) are a superfamily of receptors expressed in sensory neurons that are
known to transmit somatic sensations from the skin to the central nervous system. Interestingly, Mrgprs have
recently been implicated in sensory and motor functions of mucosal-associated neuronal circuits. The gastro
intestinal and pulmonary tracts are constantly exposed to noxious stimuli. Therefore, it is likely that neuronal
Mrgpr signaling pathways in mucosal tissues, akin to their family members expressed in the skin, might relay
messages that alert the host when mucosal tissues are affected by damaging signals. Further, Mrgprs have been
proposed to mediate the cross-talk between sensory neurons and immune cells that promotes host-protective
functions at barrier sites. Although the mechanisms by which Mrgprs are activated in mucosal tissues are not
completely understood, these exciting studies implicate Mrgprs as potential therapeutic targets for conditions
affecting the intestinal and airway mucosa. This review will highlight the central role of Mrgpr signaling
pathways in the regulation of homeostasis at mucosal tissues.

1. Mrgprs recognized role in somatosensation
Mas-related G protein coupled receptors (Mrgprs) comprise a large
family of seven transmembrane-domain receptors expressed in sensory
neurons of the dorsal root (DRG) and trigeminal ganglia (TG) that have
been traditionally studied in the context of itch, pain, touch, and tem
perature [1,2]. From the time of their discovery until recent times, much
excitement has been generated about this unique family, whose
expression predominates in sensory neurons that govern aversive be
haviors. This has raised the intriguing possibility that members of this
family could make potent therapeutic targets, with limited off-target
effects due to their relatively restrictive expression patterns in the pe
riphery outside of the brain. Based on their sequence, the Mrgpr family is
subdivided into nine separate subfamilies, with eight of these (A–H)
expressed in mice and one (X) exclusively in humans [2]. Further,
expression of Mrgpr family members has been detected in other verte
brates including rats, gerbils, Canis lupus, Gallus gallus and Bos taurus [2,
3]. The study of Mrgprs has been challenging, in part due to the dif
ferences in the number of receptors expressed by mice and humans.

Specifically, mice express at least 27 protein-coding Mrgpr family
members classified into 8 subfamilies (A–H), whereas humans express
only eight Mrgpr proteins and only four of them exhibit clear sequence
homology to their murine counterparts [2,3]. Nonetheless, two of the
human-specific receptors that belong to the MRGPRX family (MRPGRX1
and MRGPRX2) exhibit functional similarities with murine Mrgprs. For
example, human MRGPRX1 mediates itch response to the pruritogens
chloroquine and BAM8-22 that stimulate the murine MrgprA3 and
MrgprC11, respectively [4,5]. Despite differences in the numbers of
Mrgprs between mice and humans, such studies suggest that murine
studies may inform the importance of these receptors in sensory pro
cesses in humans.
The large number of genes in the MrgprA and MrgprC clusters is
thought to be due to insertion of an L1 retro-transposon into the 3′ end of
the MrgprA gene as well as unequal crossover events, resulting in the
presence of protein-coding sequences of MrgprA-C subfamilies in highly
repetitive regions of genomic DNA [6]. Therefore, targeting members of
the MrgprA-C subfamilies has been challenging. Further complicating
these studies, compensatory effects of subfamily members with similar
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sequence identity have already provided confounding results [1]. To
overcome these challenges, Liu and colleagues generated a mouse model
that lacks a cluster of Mrgpr genes (Cluster− /− ) that include the se
quences of 12 protein-coding family members including Mrgpra1,
Mrgpra3, and Mrgprc11 [4], which have been extensively studied for the
role of Mrgprs in itch response to pruritogens.
Pain and itch are distinct unpleasant sensations that evoke unique
behavioral responses such as “withdrawal” to avoid a noxious stimulus
or “scratching” to alleviate removal of a pruritic substance. As
mentioned earlier, landmark studies of Mrgpr functions, especially with
the use of Cluster− /− mice, have provided critical insight into the
neuronal circuits that transmit itch [4]. For example, while Cluster− /−
mice had intact acute pain responses to mechanical and thermal stimuli
as well as histamine-mediated pruritus, they proved to be resistant to
chloroquine-induced itch [4]. Further, DRG neurons from Cluster− /−
mice failed to exhibit calcium (Ca2+) responses or firing of action po
tentials (APs) when stimulated with chloroquine. Heterologous expres
sion of MrgprA3 in HEK293 cells defined this receptor as the primary
sensor for chloroquine [4]. Human MRGPRX1 also mediated similar
responsiveness to chloroquine, suggesting that this receptor is a func
tional ortholog of murine MrgprA3. Subsequent studies have demon
strated the relative specificity of MrgprA3 as an itch-specific receptor
[7], suggesting that it may label a subset of sensory afferents that code
exclusively for itch behavior but not pain responsiveness. Nonetheless, a
recent study showed that while metabotropic chemogenetic stimulation
of MrgprA3+ neurons induced by chloroquine evokes itch behavior, fast
ionotropic optogenetic activation of the same neurons resulted in pain
responses [8]. Thus, additional studies are required to determine the
extent to which MrgprA3 defines the pruriceptive identity of specific
sensory neurons.
Cluster− /− mice, in which Mrgprc11 is also ablated, were shown to be
unresponsive to BAM8-22 injection, the ligand for MrgprC11 [4].
Similar to MrgprA3, heterologous expression of murine MrgprC11 or
human MRGPRX1 in HEK293 cells conferred responsiveness to
BAM8-22, suggesting that both murine MrgprA3 and MrgprC11 exhibit
some degree of functional homology with human MRGPRX1 [4].
Further, a recent study revealed that MrgprC11 is expressed by a subset
of itch-sensing skin neurons with extensive axonal branching that are
also enriched for several pruritogenic receptors and soluble mediators
including MrgprA3, histamine H1 receptor, Nppb and NMB [9]; which
suggests that MrgprC11 may label different types of itch-inducing sen
sory afferents. Cysteine proteases including protease-activated receptor
2 (PAR2) and cathepsin S have also been reported to induce pruritus by
activating MrgprC11 [10,11]. While the N-terminal tethered peptide
SLIGRL, derived from PAR2, was identified as the ligand for MrgprC11,
cathepsin S directly stimulates MrgprC11 by cleaving its N-terminal site,
suggesting differential activation of MrgprC11 by different cysteine
proteases [11]. Interestingly, SLIGRL was found to activate human
MRGPRX2 but not MRGPRX1, highlighting the complex relation of
murine and human Mrgprs.
In contrast to the lack of human homologs to many members of the
MrgprA-C subfamilies, the subfamilies MrgprD-G are comprised of only
one receptor each that is conserved across rodents and humans. In
particular, MrgprD is expressed in skin-innervating non-peptidergic
DRG neurons and mediates itch behavior and firing of action potentials
evoked by the amino acid β-alanine [12,13]. Interestingly,
MrgprD-deficient DRG neurons have also been reported to show lower
sensitivity to mechanical and thermal noxious stimuli, suggesting that
MrgprD may participate in broader nociception beyond itch [14].
Indeed, genetic ablation of MrgprD+ neurons reduced responsiveness to
noxious mechanical stimuli but did not affect their thermal sensitivity
[15]. Further, an optogenetic approach in which channelrhodopsin
(ChR2) expression is induced by the Mrgprd gene (MrgprD-ChR2+ mice
[16]) demonstrated that photostimulation of MrgprD+ nociceptors
triggered “pain-like” paw withdrawal responses in mice with chronic
inflammation [17]. Interestingly, MrgprD+ neurons were found to be

responsive to extracellular ATP and use this mechanism to respond to
tissue injury [18].
Contrary to MrgprA-D family members, expression of MrgprE and
MrgprF, and their human homologs, is not restricted to DRG neurons.
While MrgprE is expressed in the spinal cord, sciatic nerve, and different
areas of the brain including cerebral cortex, medulla, and cerebellum
[19,20]; MrgprF expression was detected in uterus, gut, vas deferens,
brain, and aorta [21]. Likewise, human MRGPRE was reported to be
enriched in the pons and medulla regions of the brain, whereas MRGPRF
expression is localized mainly in the cerebellum [22]. However, the
precise functions and ligands of MrgprE and MrgprF remain poorly
characterized. MrgprE-deficient mice have not exhibited major alter
ations in nociception [23] and the effects of targeting MrgprF have not
been characterized. Nonetheless, these findings demonstrate that
Mrgprs can be expressed in visceral tissues that are innerved by sensory
neurons like the skin. As stated above, skin Mrgprs are mostly recog
nized as crucial receptors for somatosensation [1,2], therefore, it is
plausible that their visceral counterparts participate in the sensing of
damaging signals in visceral tissues, particularly those exposed
constantly to noxious stimuli such as the gastrointestinal (GI) tract and
airways. However, the functions of Mrgprs expressed in mucosal sites
remain to be defined. Therefore, we will focus on the reported contri
butions of this large superfamily of receptors in visceral-associated
neurons and other non-neuronal cell populations.
2. Contributions of Mrgprs in mucosal-associated neurons
2.1. Functions of Mrgprs in enteric neurons
Interoception refers to the process of sensing and relaying messages
from endogenous signals within the body. In recent times, with the
emergence of murine genetic tools, the neuronal circuits that govern
interoception are being identified with molecular resolution [24–26]. In
response to these sensations, the host elicits different mechanisms
designed to maintain homeostasis including reflexes (baroreflex),
motivational drivers (hunger and thirst) or bodily sensations (visceral
pain). Despite the critical relevance of the neuronal circuits that mediate
interoception, our understanding of these pathways is greatly limited.
The GI tract is innervated by autonomic neurons that provide both
sympathetic and parasympathetic input to regulate a variety of physi
ologic functions. Additionally, a vast network of neurons referred to as
the enteric nervous system (ENS), operates independently of the central
nervous system to regulate GI motility as well as secretory and absorp
tion functions. Despite being capable of functioning independently, the
ENS can be regulated by autonomic input from the vagus nerve and
prevertebral ganglia. Additionally, the cell bodies of colonic vagal af
ferents are located within the nodose and jugular ganglia, while the cell
bodies of spinal splanchnic and pelvic afferents are located in the DRG of
the thoracolumbar and lumbosacral spinal segments. Although these
spinal afferents have been proposed to relay high-threshold sensations
including pain and discomfort, the molecular and cellular pathways that
relay those messages remain poorly defined.
In contrast to the well-described role of Mrgprs in somatosensation,
particularly itch and pain responses, the contributions of these receptors
in interoceptive processes are unclear. Emerging studies have started to
address whether Mrgprs participate in the functions of neurons inner
vating visceral organs. For example, MrgprA3 and MrgprC11 were found
to be expressed by discrete subsets of thoracolumbar DRG neurons that
innervate the colon [27,28]. Interestingly, while MrgprA3+ and
MrgprC11+ neurons in skin-innervating DRG have been shown to nearly
overlap [16], MrgprA3 and MrgprC11 in colonic neurons exhibited
partial co-expression [27], which may suggest different functions
compared to their skin counterparts. Retrograde tracing demonstrated
that MrgprA3+ and MrgprC11+ neuronal bodies are housed in thor
acolumbar and lumbosacral DRG and MrgprA3+ and MrgprC11+ neu
rons also co-expressed the cation channel proteins TRPV1 and TRPA1
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[27,28]. Given the well-defined role of TRP channels in mediating
somatosensation, these findings suggest that these neurons may operate
as sensory afferents. Further, ex vivo stimulation of colonic afferents with
chloroquine or BAM8-22 induced mechanical hypersensitivity and Ca2+
responses. A portion of chloroquine- and BAM8-22-responsive colonic
neurons also reacted to AITC and capsaicin further suggesting that
MrgprA3- and MrgprC11-expressing colonic neurons overlap with
TRPA1+ and TRPV1+ sensory afferents [27]. Critically, intracolonic
administration of chloroquine or BAM8-22 enhanced the visceromotor
response to colorectal distention in wildtype mice but not in Cluster− /−
mice, confirming that stimulation of MrgprA3 or MrgprC11 elevates
visceral hypersensitivity [28]. Moreover, intracolonic stimulation of
MrgprA3+ and MrgprC11+ sensory afferents decreases the locomotor
activity and increases grooming behavior without triggering itch [27].
In addition to these exciting results, MrgprA3-expresing neurons were
surprisingly reported to innervate the meninges [29], however, whether
these afferents have a sensory function in this internal tissue remains to
be defined. Thus, although traditionally classified as itch-specific re
ceptors, emerging studies on the role of Mrgprs in neurons innervating
visceral organs suggests unique functions in regulating their physiology
(Fig. 1).
Chronic visceral pain is a debilitating symptom in disease states such
as irritable bowel syndrome (IBS) or inflammatory bowel disease (IBD).
Therefore, the contributions of MrgprA3 and MrgprC11 were evaluated
in an experimental model of trinitrobenzenesulphonic acid (TNBS)induced colitis. In this model, mice exhibit chronic mechanical hyper
sensitivity in colonic neurons despite inflammation being resolved in the
acute phase of treatment. Strikingly, colonic afferents of TNBS-treated
mice exhibited increased mechanical hypersensitivity that was further

exacerbated by treatment with MrgprA3 and MrgprC11 agonists [27].
However, whether Cluster− /− mice are resistant to the mechanical hy
persensitivity induced by TNBS was not evaluated. Importantly,
TNBS-induced colitis resulted in elevated MrgprC11 expression and
increased the proportion of MrgprA3 and MrgprC11 co-expression.
Translating these murine studies, human thoracolumbar DRG neurons
were also found to co-express the homolog MRGPRX1 along with TRPV1
and responded to chloroquine and BAM8-22 [27,28]. These responses
were enhanced when DRG neurons were exposed to an inflammatory
cocktail containing histamine, PGE2, serotonin, bradykinin [27]. Taken
together, these studies reveal a previously unappreciated role of
MrgprA3 and MrgprC11 in the context of inflammation-induced intes
tinal motility, suggesting that Mrgprs may operate in autonomic me
chanical functions of the GI tract. However, whether colonic neurons
sense endogenous Mrgpr ligands to exacerbate visceral hypersensitivity
remains unclear.
Similar to MrgprA3 and MrgprC11, retrograde labelling of colonic
sensory afferents revealed MrgprD expression in a discrete neuronal
subset [30]. Further, MrgprD was required by colonic neurons to
respond to 5-oxo-eicosatetraenoic acid (5-oxoETE), a polyunsaturated
fatty acid enriched in biopsies from IBS patients. Moreover, heterolo
gous expression of MrgprD conferred 5-oxoETE responsiveness in
HEK293 cells and MrgprD-deficient mice were resistant to 5-oxoETE-in
duced visceral hypersensitivity after colorectal distension [30].
Remarkably, MrgprD expression was also found in human DRGs that
also exhibit calcium responses to 5-oxoETE [30], suggesting that murine
and human MrgprD may be functional homologs. Although MrgprD
expression was also originally reported outside of DRG neurons in
lamina propria macrophages and lymphocytes [31], analysis of
Fig. 1. Mrgpr signaling in visceral-associated
neurons. MrgprA3 and MrgprC11 expressed in
skin-innervating dorsal root ganglia (DRG)
sensory neurons are well recognized to partici
pate in somatosensation processes such as itch,
pain, and temperature. However, a growing
body of evidence has identified the expression
of Mrgpr family members in vagal and DRG
sensory afferents innervating mucosal tissues
like the lungs and GI tract. Although activation
of these signaling pathways by exogenous
(chloroquine and BAM8-22) or endogenous
(NPFF and 5-oxoETE) ligands induces auto
nomic functions including bronchoconstriction
and visceral hypersensitive, whether Mrgprs
relay messages that inform on the internal state
of the body (interoception) remains unclear.
Images created using Biorender.com.
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MrgprD-deficient mice indicate that such expression is unlikely [32],
highlighting the need to perform retrograde tracing approaches to
confirm the sensory nature of Mrgpr-expressing neurons in visceral or
gans. Similarly, MRGPRD mRNA expression is reported in human in
testinal tissue [33], however, further studies are required to determine
the specific cellular compartment that expresses MrgprD and its function
on such cells. MrgprE and MrgprF were found to be expressed in the
ileum of naïve mice, which was reduced in mice undergoing
TNBS-induced colitis [34]. Further characterization of MrgprE and
MrgprF expression revealed that both receptors were present in three
main enteric neuronal compartments: (1) nerve fibers of the tunica
muscularis and lamina propria as well as in (2) neuronal somata and
fibers of the myenteric and (3) submucosal enteric plexus. To assess
whether MrgprE and MrgprF expression is affected by inflammatory
stimuli, TNBS-induced colitis and parasitic infection with Schistosoma
mansoni experimental models were evaluated. In the lamina propria,
intestinal inflammation provoked by S. mansoni infection resulted in
elevated numbers of MrgprE+ and MrgprF+ neurons whereas MrgprEand MrgprF-expressing neurons were severely reduced in mice subjected
to TNBS-induced colitis [34], suggesting complexity on the effects of
intestinal inflammation regarding Mrgpr enteric neuron expression.
Based on the co-expression patterns of MrgprE + and MrgprF + neurons
in the myenteric plexus with calretinin (CRT), calbindin (CB), and
neuronal nitric oxidase synthase (nNOS), MrgprE and MrgprF were
proposed to be expressed in sensory neurons as well as motor and in
terneurons [34]. Nonetheless, further retrograde labeling is required to
confirm this possibility. Importantly, the co-expression of CRT, CB and
nNOS within MrgprE + and MrgprF + neurons was significantly reduced
in mice with TNBS-induced intestinal inflammation but not in S. mansoni
infected mice. Similarly, MrgprE + and MrgprF + neurons of the sub
mucosal plexus expressed CRT and the neuropeptide vasoactive intes
tinal peptide (VIP), suggesting that these afferents are secretomotor or
vasodilator neurons. In the submucosal plexus, CRT and VIP
co-expression with MrgprE and MrgprF was significantly reduced in
S. mansoni-infected and TNBS-treated mice. Of note, poor co-expression
of MrgprE and MrgprF was detected in both the myenteric and submu
cosal plexus, suggesting MrgprE and MrgprF may label discrete subsets
of enteric neurons [34]. Thus, although originally known for their
expression on somatosensory neurons, the functional identity of
MrgprD, and particularly MrgprE and MrgprF, in terms of their potential
sensory, motor, and peptidergic properties requires further
investigation.

originally identified as a marker for somatosensory neurons in the skin,
and more recently as potential receptors on visceral afferents in the gut,
studies in the lung ascribe Mrgpr expression and function in vagal sen
sory neurons. Nonetheless, it remains to be determined whether other
Mrgpr family members, such as MrgprA3, are expressed in the
airway-innervating afferents and what are the noxious signals that
stimulate Mrgprs in the lungs.
Airway stimulation of MrgprC11+ afferents with BAM8-22 increased
the amplitude of the respiratory waveform and elevated the respiratory
rate of wildtype mice, an effect absent in BAM8-22-treated Cluster− /−
mice [35]. Moreover, blocking of the muscarinic acetylcholine receptor
(mAChR) also prevented the respiratory effects of BAM8-22 treatment,
confirming that MrgprC11-expressing afferents relay messages to the
vagus nerve. Importantly, BAM8-22 treatment increased lung resistance
that was inhibited by mAChR blocker and surgical vagotomy, suggesting
that MrgprC11 signaling activates the parasympathetic vagus nerve and
induces cholinergic bronchoconstriction [35]. To evaluate whether
MrgprC11 signaling contributes to bronchoconstriction during patho
logic conditions, control and Cluster− /− mice were subjected to an
anaphylactic experimental model induced by ovoalbumin (OVA) sensi
tization. Remarkably, while OVA induced airway hyperresponsiveness
in sensitized wildtype mice, Cluster− /− mice were resistant to this
anaphylactic response [35]. Further, treatment with the MrgprC11
agonist, Neuropeptide FF, also induced bronchoconstriction in a
Mrgpr-cluster-dependent manner. Moreover, Cluster− /− mice exhibited
reduced airway hyperresponsiveness induced by influenza A virus (IFA)
compared to wildtype animals despite presenting with similar immune
cell infiltrates, suggesting that MrgprC11 signaling induces broncho
constriction independently of lung inflammation [35]. In support of this
possibility, BAM8-22 pre-treatment increased the airway responsiveness
elicited by methacholine, which directly acts on smooth muscles and
vagal nerves to induce bronchoconstriction in the absence of inflam
mation, an effect that was abolished in Cluster− /− mice or by surgical
vagotomy. Altogether, these elegant studies indicate that in addition to
the sensory functions that MrgprC11 may perform in the airways, it also
participates in autonomic reflexes induced by the vagus nerve (Fig. 1).
Interestingly, treatment with the MrgprC11 agonists SLIGRL, which
is derived from PAR2, or BAM8-22 was reported to reduce the immune
cell infiltrate into the airways of IFA-infected mice [39,40]. However,
this immunoregulatory effect was also observed in PAR2− /− or
Cluster− /− mice [39,40], suggesting that SLIGRL may function inde
pendently of MrgprC11 stimulation in this context and requires further
investigation. Notwithstanding this, the pharmacological potential of
activating MrgprC11 to regulate airway hyperresponsiveness and its
ability to act as a substrate for pathogens remains unclear. The cysteine
protease Der p 1 is an allergen derived from house dust mites that has
been reported to act on PAR2 receptors to promote airway inflamma
tion. Stimulation with Der p 1 induced calcium responses in HELA cells
transfected with mMrgprC11 or hMRGPRX1 associated with IL-6
secretion [41]. However, it is unclear if Der p 1 or other cysteine pro
teases directly act on MrgprC11-expressing neurons to induce bron
choconstriction. Taken together, these studies uncover a previously
unappreciated role of MrgprC11+ sensory neurons in the regulation of
lung function and airway responsiveness, urging the study of other
Mrgprs originally identified in skin sensory afferents.

2.2. MrgprC11 participates in airway hyperresponsiveness
Given the emerging studies with regard to previously unappreciated
roles of Mrgprs in the GI tract, whether Mrgpr signaling operates in other
mucosal tissues, such as the lungs, is also an exciting field of inquiry.
Similar to the GI tract, the lungs and upper airways are innervated by
sensory afferents derived from the vagus nerve and DRG [24,35]. In
addition to other ion channels recently identified to regulate airway
hyperresponsiveness including TRPV1 and TRPA1 [36–38], MrgprC11
was proposed to regulate the activity of the lungs in stressing conditions
such as asthma. MrgprC11 is expressed in TRPV1-expressing small
diameter jugular sensory neurons of the vagal ganglia [35]. Retrograde
tracing further demonstrated that jugular sensory neurons that inner
vate the airways are MrgprC11+, whereas none of the
airway-innervating DRG neurons were positive for MrgprC11. These
findings are intriguing considering that MrgprC11+ neurons from the
DRG have traditionally been known to innervate the skin and mediate
itch sensation [4]. As expected, ex vivo BAM8-22 induces Ca2+ responses
and firing of action potentials of MrgprC11+ vagal jugular neurons from
wildtype but not Cluster− /− mice. Further, administration of BAM8-22
directly into the airways elicits robust Ca2+ responses of vagal sensory
neurons, reinforcing the hypothesis that MrgprC11 labels a subset of
jugular sensory neurons that innervate the airways [35]. Thus, although

3. Mrgprs mediate cross-talk between sensory neurons and mast
cells
Neuroimmunology is a rapidly emerging field, in part due to the
seminal discovery that the stimulation of the vagus nerve triggers a
cholinergic anti-inflammatory reflex that protects against lethal endo
toxaemia [42]. Similarly, barrier sites that are densely innervated by
sensory and autonomic nerves are also populated by a myriad of
tissue-resident immune cells, offering the ideal location for sensory
neurons and immune cells to communicate during homeostatic and
4
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inflammatory conditions. Critically, recent studies have positioned
Mrgprs at the center of this cross-talk between neurons and immune
cells. In an interesting aberration of the aforementioned studies, murine
MrgprB2 and its human functional homolog MRGPRX2, are expressed
outside of the nervous system, with high enrichment in mast cell (MC)
populations [43–45]. MCs are granulocytic innate immune cells that
populate connective tissues and barrier sites such as the skin, lungs and
GI tract. Although MCs are mostly recognized for their critical contri
butions to allergic inflammation and anaphylaxis, they play critical
host-protective functions in response to a myriad of pathogens including
bacteria, fungi and helminth parasites. Upon activation, MCs are
well-known to trigger robust inflammatory responses by releasing their
secretory granules containing several bioactive and immunomodulatory
molecules including lysosomal enzymes (β-hexosaminidase), biogenic
amines (histamine and serotonin), proteases (Mcpt1, tryptase and chy
mase), bioactive lipids (prostaglandins and leukotrienes), cytokines
(TNFα and IL-4), chemokines and antimicrobial peptides. MC activation
and degranulation is traditionally known to occur by binding of mi
crobial or allergen-derived antigens to surface-bound immunoglobulin E
(IgE) and crosslinking of the high-affinity IgE receptor, Fc epsilon RI
(FcεRI). However, emerging studies indicate that MrgprB2/X2 activa
tion can drive MC degranulation independently of the actions of
IgE-mediated antigen stimulation [43–45]. Specifically, while
IgE-induced stimulation of human MCs promotes sustained elevation of
intracellular Ca2+ and formation of large heterogeneously shaped
granules, MRGPRX2 activation led to rapid calcium responses and
secretion of small spherical granules [46]. Accordingly, MrgprB2 stim
ulation of murine MCs provoked rapid systemic anaphylactic responses,
while IgE-mediated MC degranulation resulted in slower and prolonged
vascular leakage [46], suggesting differential effector responses. Of
note, MrgprB2/X2 stimulation in MCs triggered robust Ca2+-dependent
responses similar to other Mrgpr family members expressed in sensory
neurons, suggesting that Mrgpr signaling operates by a shared down
stream mechanism in ontogenically distinct cells.
A unique feature of MrgprB2/X2 is that it is activated by a multitude
of exogenous and endogenous molecules. Drug-induced anaphylactic
reactions are severe life-threatening hypersensitivity reactions where
the central role of MCs is well-documented [47]. Several FDA-approved
peptidergic drugs have cationic properties suggesting they can activate
MCs by stimulation of MrgprB2/X2. Indeed, MrgprB2- or
MRGPRX2-expressing HEK293 cells presented Ca2+ responses induced
by a myriad of cationic peptidergic drugs including icatibant and leu
prolide [43]. Moreover, stimulation with cationic drugs promotes his
tamine release and local vascular leakage in an MrgprB2-dependent
fashion. Small molecule drugs that have been reported to induce
pseudo-allergic reactions including neuromuscular blocking drugs and
fluoroquinolone antibiotics also induce MC activation that is dependent
on MrgprB2 expression [43]. In addition to pharmacological agents, the
endogenous neuropeptide cortistatin-14 was identified as a ligand of
MRGPRX2 that causes human MC degranulation [43,48]. Moreover,
cutaneous injection of high dose Sinomenine, a natural alkaloid with
therapeutic properties for rheumatoid arthritis, causes vascular leakage
that is reversed in MC-deficient or MrgprB2− /− mice [49]. Further,
MrgprB2 expression was required by Sinomenine to cause Ca2+
signaling in murine MCs. Sinomenine also induces degranulation of
human MCs and chemokine secretion dependent on MRGPRX2 expres
sion [49]. Similarly, mastoparan, a naturally-occurring cationic peptide,
causes MrgprB2/X2-dependent MC degranulation that promotes their
secretion of cytokines and chemokines, including TNFα and IL-8 [43,
50]. In line with these findings, mastoparan promoted skin wound
healing and neutrophil recruitment in a cutaneous infection model with
Staphylococcus aureus in an MC-dependent manner [50]. However,
additional studies using MC-specific MrgprB2− /− mouse models are
required to characterize the signaling pathways activated by these
pharmacological agents. Nonetheless, these exciting results suggest that,
while detrimental in anaphylactic conditions, MrgprB2-induced

activation of MCs contributes to efficient innate antibacterial responses.
In support of this hypothesis, the anti-microbial peptide LL-37 was re
ported to trigger degranulation and activation of human MCs that was
impaired by MRGPRX2 silencing [51]. Further, human β-defensins
(hBDs), which are cationic antimicrobial peptides secreted by epithelial
cells, induced the degranulation of human MCs associated with robust
intracellular Ca2+ mobilization that was impaired by partial silencing of
MRGPRX2 expression [52]. Collectively, these exciting studies demon
strate the complex roles of MrgprB2/X2 signaling in response to both
exogenous and endogenous signals, as well as in allergic pathology and
protective antibacterial responses.
Beyond revealing new modes of MC regulation, MrgprB2 expression
appears to vary depending on the anatomic location of MCs. For
example, both peritoneal and bone-marrow derived MCs have been re
ported to express MrgprB2 [43], while MRGPRX2 is expressed in human
skin and synovial MCs, but not lung MCs [45,53,54]. The heterogeneity
of MrgprB2/MRGPRX2 expression across different populations of MCs
suggests diversity in their functions as well. In addition to cationic small
molecule drugs and antibiotics, a number of basic secretagogues have
been described to stimulate MCs by directly acting on MrgprB2/X2
including substance P (SP), proadrenomedullin amino-terminal 20
peptide, fragment 9–20 (PAMP(9–20)), and compound 48/80 [43,44,
55,56]. Following ligand binding, MrgprB2/X2 activation promotes
dissociation of Gαq subunit to elicit intracellular Ca2+ flux that activates
PLC signaling [57]. Taken together, MrgprB2/X2 signaling is now
recognized as a central activation pathway of MCs in response to a va
riety of stimulants and tissue-derived signals that may confer a diversity
of functions across numerous organs.
MCs and peripheral sensory neurons reside in close proximity at
barrier surfaces such as the skin, lungs, and intestine [58,59]. Based on
this anatomic relationship, MCs have been proposed to communicate to
sensory neurons through the release of a variety of factors including
monoamines, neuropeptides, and cytokines [60]. Along these lines,
MrgprB2 has been recently highlighted to mediate MC-neuron in
teractions in the context of pain, itch and allergic inflammation.
MrgprB2− /− mice have reduced pain sensitivity associated with dimin
ished local immune cell infiltrate and chemokine secretion in a model of
post-operative pain [61]. Further, nerve injury in this neurogenic model
was reported to be associated with their expression of SP, a ligand for
MrgprB2 [54]. While blocking of SP recapitulated pain resistance
observed in MrgprB2− /− mice, SP treatment induced immune cell
recruitment in wildtype but not MrgprB2− /− mice independently of
neurokinin-1 receptor (NK1-R) expression, the classical receptor of SP.
As mentioned above, Mrgpr family members are well known to
contribute to itch perception on sensory neurons, and a recent study
indicates that MrgprB2+ MCs also contributes to pruritogenic responses.
PAMP(9–20) or compound 48/80 induced non-histaminergic itch that
was impaired in MrgprB2-deficient animals or mice lacking mast cells
[62]. However, IgE-induced histaminergic itch was not altered by the
lack of MrgprB2 expression. Critically, MrgprB2-mediated activation of
MCs induced their release of tryptase and low levels of serotonin
whereas IgE-induced MC activation preferentially promoted the release
of histamine and higher levels of serotonin. Injection with MrgprB2
agonists more efficiently activated a broad array of MrgprD+,
MrgprA3/C11+, and 5-HT1F+ (serotonin receptor) itch-specific neu
rons, while IgE activation triggered histamine-sensitive neurons, indi
cating that MCs activate distinct populations of sensory neurons in
response to MrgprB2. Importantly, MrgprB2− /− mice exhibit reduced
itch behavior in experimental models of allergic contact dermatitis
(ACD) associated with diminished immune cell infiltrates [62]. More
over, adrenomedullin, the endogenous PAMP9-20 precursor, was
enriched in skin explants from ACD patients, suggesting that
MRGPRX2-mediated mechanism may contribute to the chronic pruritus
characteristic of ACD. In slight contrast, in a house dust mite model of
allergic dermatitis, SP-deficient mice exhibit reduced skin inflammation
and milder pathology [59]. Skin-innervating sensory neurons were
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found to be highly enriched for SP expression and proteases derived
from house dust mite extracts can directly stimulate DRG neurons to
release SP [59], thereby stimulating MrgprB2 on MCs. Sensory neurons
and SP were required for allergen-induced MC degranulation which
resulted in clusters of dermal MCs in close proximity to sensory neurons
[59]. Collectively, these studies highlight how MrgprB2 may represent a
key regulator of MC-neuronal neuroimmune interactions in the skin and
potentially other barrier surfaces (Fig. 2). Importantly, other Mrgpr
family members were shown to be highly enriched in other immune cell
populations such as MrgprA6 in basophils [63], urging the study of this
critical signaling pathway in innate and adaptive immune cells.
In addition to MrgprB2, MC populations were reported to express
other Mrgpr family members including MrgprE, MrgprA4 and low levels
MrgprC11 [63,64]. Importantly, stimulation with neuropeptide AF
(NPAF), an MrgprA4 reported ligand, induced oscillatory calcium
signaling in wildtype MCs but not in those derived from Cluster− /− mice
[64]. Moreover, partial degranulation as well as Mcpt1 release were
induced following stimulation of MCs with NPAF. NPAF and its pre
cursor pro-NPFF belong to the family of RFamide-related peptides
expressed in several regions of the CNS [65]. Interestingly, RFamide
expression was detected in enteroendocrine cells in the ileum and colon
as well as in nerve fibers of the submucosal and myenteric plexus that
also co-expressed tyrosine hydroxylase suggesting these fibers are
extrinsic afferents of sympathetic origin [65]. In line with these studies,
MC populations expressed RF-amide peptides that were secreted upon
degranulation induced by IgE-crosslinking [66]. Moreover, stimulation
of MrgprC11-expressing cells with NPFF or IgE-activated MCs promoted
Ca2+ responses. Although these results propose that MCs communicate
with sensory neurons by their secretion of RF-amide peptides that
activate MrgprC11 (Fig. 2) [66], additional MC- and neuron-specific
gene ablation approaches are required to confirm this hypothesis.
Furthermore, a recent study has shown that activation of skin sensory
neurons by the proteolytic action of allergens such as papain results in
their release of substance P, which in turn promotes the migration and
activation of dendritic cells in a MrgprA1-dependent manner [67].
Collectively, these exciting studies may reveal a novel circuit in which
Mrgpr family members and their ligands represent an essential mecha
nism that mediates neuroimmune cross-talk at barrier sites.

Fig. 2. Mrgprs facilitate cross-talk between sensory neurons and mast cells.
Mucosal tissues provide an ideal context for interactions between sensory
neurons and immune cells such as mast cells. Mrgpr family members are now
recognized to mediate the interactions between immune cells and neurons.
While substance P released by sensory neurons activates MrgprB2/X2 expressed
in mast cells, their degranulation of tryptase or RF-amide peptides was pro
posed to signal back to sensory neurons by stimulation of MrgprC11/X1expresseing neuronal fibers. Although further studies are required to confirm
this possibility, these exciting findings suggest that Mrgprs are central media
tors of neuroimmune cross-talk in visceral organs. Images created using Bio
render.com.
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4. Concluding remarks
Mrgpr family members are well recognized to mediate a variety of
somatosensory responses including itch and pain. However, emerging
recognition of their expression outside of the DRG, including vagal
neurons that innervate visceral organs, suggests other sensory functions
that communicate the internal state of the host. However, it remains to
be investigated whether Mrgprs in such neuronal populations may have
other physiologic properties beyond sensation to regulate organ func
tion. Notwithstanding this, identifying the endogenous ligands and
cellular interactions that elicit such neurosensory and neurophysiologic
responses presents an exciting area of future inquiry.
Another unique feature of the Mrgpr family is that MrgprB2/X2 are
preferentially expressed on MCs. Given that MCs reside in close prox
imity to peripheral neurons across numerous barrier surfaces including
the skin, airway, gut, and bladder; how MCs and their associated neu
rons are coordinately regulated by various Mrgpr ligands remains a
major open question in neuroimmunology. Although originally
described mostly in the context of somatosensation, such interactions
hold high promise for the discovery of a variety of unique sensory and
physiologic processes well beyond even mucosal immunology.
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